MTOR and lung cancer: By targeting c-Met/PI3k/AKT/mTOR (mammalian target of rapamycin) signaling, miR-206 inhibits the hepatocyte-growth-factor-induced epithelial-mesenchymal transition, the migration and invasion of lung cancer cells, as well as HUVEC migration and capillary tube formation [101,127].